EUVIMEDEUVIMED entdecken
Open Access

EGR1 functions as a new host restriction factor for SARS-CoV-2 to inhibit virus replication through the E3 ubiquitin ligase MARCH8

Yinghua Zhao iD, Liyan Sui, Ping Wu, Letian Li, Li Liu, Baohua Ma, Wenfang Wang, Hongmiao Chi, Ze-Dong Wang, Zhengkai Wei, Zhijun Hou, Kaiyu Zhang und 6 weitere

Journal of Virology · 2023

DOI: 10.1128/jvi.01028-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2023. Verfasst von Yinghua Zhao und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Center of Infectious Diseases and Pathogen Biology, Key Laboratory of Organ Regeneration and Transplantation of…. Hauptthemen laut MEDLINE: Early Growth Response Protein 1, SARS-CoV-2, Ubiquitin-Protein Ligases, Virus Replication. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), | Guangdong Provincial Pearl River Talents Program (), Scientific and Technological Research Projects of Guangzhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronavirus disease 2019, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to an unprecedented public health crisis worldwide. Though the host produces interferons (IFNs) and restriction factors to suppress virus infection, SARS-CoV-2 has evolved multiple strategies to inhibit the antiviral responses. Understanding host restriction factors and viral escape mechanisms is conducive to developing effective anti-SARS-CoV-2 drugs. Here, we constructed SARS-CoV-2 nucleocapsid (2N) protein- and green fluorescent protein (GFP)-stably expressing cells that were transfected with polyinosinic-polycytidylic acid (poly(I:C)) to activate IFN responses. The transcriptome analysis showed that poly(I:C)-induced IFN responses were inhibited by the SARS-CoV-2 N protein. Further analysis revealed that 2N inhibited the production of IFN-stimulated genes by suppressing early growth response gene-1 (EGR1) expression, a transcription factor that can regulate multiple cellular processes. The ectopic expression of EGR1 remarkably reduced 2N expression and suppressed SARS-CoV-2 replication. Mechanistically, EGR1 promoted expression of IFN-regulated antiviral protein (IRAV), which interacted with 2N to induce its degradation via the E3 ubiquitin ligase MARCH8 with the cargo receptor NDP52 in a lysosome-dependent pathway. MARCH8 catalyzed the K48-linked polyubiquitination of 2N at the lysine residue 143, and knockout of endogenous MARCH8 reversed IRAV-mediated 2N degradation. Additionally, the overexpression of IRAV or MARCH8 could inhibit SARS-CoV-2 replication. Our findings reveal that EGR1 is a new host restriction factor to inhibit SARS-CoV-2 replication through the E3 ubiquitin ligase MARCH8, which would contribute to understanding the pathogenesis of emerging coronaviruses. IMPORTANCE Emerging vaccine-breakthrough severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants highlight an urgent need for novel antiviral therapies. Understanding the pathogenesis of coronaviruses is critical for developing antiviral drugs. Here, we demonstrate that the SARS-CoV-2 N protein suppresses interferon (IFN) responses by reducing early growth response gene-1 (EGR1) expression. The overexpression of EGR1 inhibits SARS-CoV-2 replication by promoting IFN-regulated antiviral protein expression, which interacts with and degrades SARS-CoV-2 N protein via the E3 ubiquitin ligase MARCH8 and the cargo receptor NDP52. The MARCH8 mutants without ubiquitin ligase activity are no longer able to degrade SARS-CoV-2 N proteins, indicating that MARCH8 degrades SARS-CoV-2 N proteins dependent on its ubiquitin ligase activity. This study found a novel immune evasion mechanism of SARS-CoV-2 utilized by the N protein, which is helpful for understanding the pathogenesis of SARS-CoV-2 and guiding the design of new prevention strategies against the emerging coronaviruses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Early Growth Response Protein 1SARS-CoV-2Ubiquitin-Protein LigasesVirus ReplicationHost Microbial InteractionsHumansCOVID-19Drug DiscoveryUbiquitinsNuclear ProteinsPhosphoproteinsCoronavirus Nucleocapsid Proteins

Stichwörter der Autor:innen

EGR1IFN-regulated antiviral proteinMARCH8SARS-CoV-2interferonnucleocapsid protein

Substanzen

Early Growth Response Protein 1Ubiquitin-Protein LigasesUbiquitinsCALCOCO2 protein, humanNuclear ProteinsEGR1 protein, humanMARCHF8 protein, humannucleocapsid phosphoprotein, SARS-CoV-2PhosphoproteinsCoronavirus Nucleocapsid Proteins

Autor:innen und Institutionen

  • Department of Infectious Diseases and Center of Infectious Diseases and Pathogen Biology, Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, State Key Laboratory for Diagnosis and Tre…
  • College of Wildlife and Protected Area, Northeast Forestry University , Harbin, China.
  • Research Unit of Key Technologies for Prevention and Control of Virus Zoonoses, Chinese Academy of Medical Sciences, Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences , Changchun, China.
  • Department of Pathogenbiology, The Key Laboratory of Zoonosis, Chinese Ministry of Education, College of Basic Medicine, Jilin University , Changchun, China.
  • School of Life Sciences and Engineering, Foshan University , Foshan, China.
  • Department of Pediatric Surgery, The First Hospital of Jilin University , Changchun, China.

ORCID-Profile: Yinghua Zhao, Guoqing Wang, Quan Liu

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • | Guangdong Provincial Pearl River Talents Program ()
  • Scientific and Technological Research Projects of Guangzhou
  • MOST | National Key Research and Development Program of China (NKPs)
  • 广东省人力资源和社会保障厅 | Guangdong Provincial Pearl River Talents Program

Zitieren

APA

Zhao, Y., Sui, L., Wu, P., Li, L., Liu, L., Ma, B., Wang, W., Chi, H., Wang, Z. D., Wei, Z., Hou, Z., Zhang, K., Niu, J., Jin, N., Li, C., Zhao, J., Wang, G., & Liu, Q. (2023). EGR1 functions as a new host restriction factor for SARS-CoV-2 to inhibit virus replication through the E3 ubiquitin ligase MARCH8. Journal of Virology. https://doi.org/10.1128/jvi.01028-23

Vancouver

Zhao Y, Sui L, Wu P, Li L, Liu L, Ma B, et al. EGR1 functions as a new host restriction factor for SARS-CoV-2 to inhibit virus replication through the E3 ubiquitin ligase MARCH8. Journal of Virology. 2023. doi:10.1128/jvi.01028-23

BibTeX
@article{Zhao2023,
  author = {Zhao, Yinghua and Sui, Liyan and Wu, Ping and Li, Letian and Liu, Li and Ma, Baohua and Wang, Wenfang and Chi, Hongmiao and Wang, Ze-Dong and Wei, Zhengkai and Hou, Zhijun and Zhang, Kaiyu and Niu, Junqi and Jin, Ningyi and Li, Chang and Zhao, Jixue and Wang, Guoqing and Liu, Quan},
  title = {EGR1 functions as a new host restriction factor for SARS-CoV-2 to inhibit virus replication through the E3 ubiquitin ligase MARCH8},
  journal = {Journal of Virology},
  year = {2023},
  doi = {10.1128/jvi.01028-23}
}
Kostenlos starten →